Macquarie Lowers Surgery Partners (NASDAQ:SGRY) Price Target to $33.00
Surgery Partners (NASDAQ:SGRY – Get Free Report) had its price target reduced by analysts at Macquarie from $34.00 to $33.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Macquarie’s price target indicates a potential upside of 41.03% from the stock’s previous close. Several other research […]
Surgery Partners (NASDAQ:SGRY – Get Free Report) had its price target reduced by analysts at Macquarie from $34.00 to $33.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Macquarie’s price target indicates a potential upside of 41.03% from the stock’s previous close. Several other research […]
